Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Analysis of the T Descriptors and Other Prognosis Factors in Pathologic Stage I Non-small Cell Lung Cancer in China

Analysis of the T Descriptors and Other Prognosis Factors in Pathologic Stage I Non-small Cell... ORIGINAL ARTICLE Analysis of the T Descriptors and Other Prognosis Factors in Pathologic Stage I Non-small Cell Lung Cancer in China Ziming Li, MD,* Yongfeng Yu, MD,* Jiade Lu, MD, MBA,‡ Qinquan Luo, MD,* Chunxiao Wu, MD,† Meilin Liao, MD,* Ying Zheng, PhD,† Xinghao Ai, MD,* Lingping Gu, MD,* and Shun Lu, MD, PhD* node sampling), and lymphovascular vessel invasion were signifi- Background: The seventh edition of the tumor, node, metastasis cant predictive factors for OS. Classification of Malignant Tumors is due to be published in 2009. The Conclusions: The tumor size is a significant independent prognostic recommendations of International Association for the Study of Lung factors in stage I NSCLC. Cancer for changes to the T descriptors have been published. We Key Words: Non-Small Cell Lung Cancer, TNM, Stage I, Progno- combined this new parameter with other well-established prognostic sis factors. factors and performed multivariate survival analyses to validate its value in Chinese stage I non-small cell lung cancer (NSCLC). (J Thorac Oncol. 2009;4: 702–709) Methods: We try to validate the new staging project in 325 patients who underwent complete surgical resection for stage I NSCLC in Single Institution of Shanghai Chest Hospital from 1998 to 2003. urgical http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

Analysis of the T Descriptors and Other Prognosis Factors in Pathologic Stage I Non-small Cell Lung Cancer in China

Lu, Shun
Journal of Thoracic Oncology , Volume 4 (6) – Jun 1, 2009
Download PDF
8 pages

Loading next page...
 
/lp/wolters-kluwer-health/analysis-of-the-t-descriptors-and-other-prognosis-factors-in-BwocHBzOQ0

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1556-0864
DOI
10.1097/JTO.0b013e3181a5269d
pmid
19404215
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL ARTICLE Analysis of the T Descriptors and Other Prognosis Factors in Pathologic Stage I Non-small Cell Lung Cancer in China Ziming Li, MD,* Yongfeng Yu, MD,* Jiade Lu, MD, MBA,‡ Qinquan Luo, MD,* Chunxiao Wu, MD,† Meilin Liao, MD,* Ying Zheng, PhD,† Xinghao Ai, MD,* Lingping Gu, MD,* and Shun Lu, MD, PhD* node sampling), and lymphovascular vessel invasion were signifi- Background: The seventh edition of the tumor, node, metastasis cant predictive factors for OS. Classification of Malignant Tumors is due to be published in 2009. The Conclusions: The tumor size is a significant independent prognostic recommendations of International Association for the Study of Lung factors in stage I NSCLC. Cancer for changes to the T descriptors have been published. We Key Words: Non-Small Cell Lung Cancer, TNM, Stage I, Progno- combined this new parameter with other well-established prognostic sis factors. factors and performed multivariate survival analyses to validate its value in Chinese stage I non-small cell lung cancer (NSCLC). (J Thorac Oncol. 2009;4: 702–709) Methods: We try to validate the new staging project in 325 patients who underwent complete surgical resection for stage I NSCLC in Single Institution of Shanghai Chest Hospital from 1998 to 2003. urgical

Journal

Journal of Thoracic Oncology – Wolters Kluwer Health

Published: Jun 1, 2009

References

  • Incidence of local recurrence and second primary tumors in resected stage I lung cancer
    Martini
  • Survival in early-stage non-small cell lung cancer
    Nesbitt
  • Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas
    Fujisawa
  • Report on the international workshop on intrathoracic staging, London, October 1996
    Goldstraw
  • The International Staging Committee of the IASLC: its origins and purpose
    Goldstraw
  • The IASLC Lung Cancer Staging Project: proposals for the revision of the t descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer
    Rami-Porta
  • Mediastinal lymph node dissection for lung cancer
    Martini
  • Lymph node mapping and curability at various levels of metastasis in resected lung cancer
    Naruke
  • Common neoplasms
    Hammar
  • Surgical results and prognostic factors in early non-small cell lung cancer
    Padilla
  • Lung cancer staging: a case for a new T definition
    Mulligan
  • How the TNM staging system for lung cancer should be revised? A simulation based on the Japanese Lung Cancer Registry populations
    Asamura
  • T2 tumors larger than five centimetres in diameter can be upgraded to T3 in non-small cell lung cancer
    Carbone
  • Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer
    Takeda
  • Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S). Clinical tumour size and prognosis in lung cancer
  • Prognostic significance of the non-size-based AJCC T2 descriptors: visceral pleura invasion, hilar atelectasis, or obstructive pneumonitis in stage IB non-small cell lung cancer is dependent on tumor size
    Ou
  • Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer: results of a prospective randomized trial
    Izbicki
  • A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer
    Wu
  • Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non small cell lung cancer. Eastern Cooperative Oncology Group
    Keller
  • Effect of number of lymph nodes Sampled on outcome in patients with stage I non-small-cell lung cancer
    Gajra
  • Long-term results of pathological Stage I non-small cell lung cancer: validation of using the number of totally removed Lymph nodes as a staging control
    Wu
  • Impact of radical systematic mediastinal lymphadenectomy on tumor staging in lung cancer
    Izbicki
  • Extent of mediastinal node metastasis in clinical stage I non-small-cell lung cancer: the role of systematic nodal dissection
    Oda
  • Systematic lymph node dissection for clinically diagnosed peripheral non-small-cell lung cancer less than 2 cm in diameter
    Sugi
  • Lung cancer in women: sex-associated differences in survival of patients undergoing resection for lung cancer
    Minami
  • Do women live longer following lung resection for carcinoma?
    Alexiou
  • Sex-associated differences in survival of patients undergoing resection for lung cancer
    Ferguson
  • A time trend of profile and surgical results in 1123 patients with non-small cell lung cancer
    Yoshino
  • The female gender has a positive effect on survival independent of background life expectancy following surgical resection of primary non-small cell lung cancer: a study of absolute and relative survival over 15 years
    Batevik
  • Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue
    Fasco
  • Lung cancer in women: emerging differences in epidemiology, biology, and therapy
    Thomas
  • Gastric adenocarcinoma: review and considerations for future directions
    Dicken
  • Surgical treatment of non-small cell lung cancer in patients 70 years of age or older
    Ciriaco
  • Surgical results of stage I non-small cell lung cancer: comparison between elderly and younger patients
    Yamamoto
  • Pneumonectomy for stage I (T1N0 and T2N0) non-small cell lung cancer has potent, adverse impact on survival
    Alexiou